Literature DB >> 11253984

Cushing's syndrome.

M Boscaro1, L Barzon, F Fallo, N Sonino.   

Abstract

During the past 30 years, there have been advances in understanding of the pathogenesis of Cushing's syndrome and in differential diagnosis of its various forms. Improved diagnostic tests and procedures have increased the ability to recognise even mild hypercortisolism and have provided the means to obtain an accurate diagnosis. Despite these advances, the occurrence of unusual clinical presentations and laboratory shortcomings may produce diagnostic problems and challenge clinical intuition. This article reviews recent pathogenic views, new tests, and new diagnostic problems in the evaluation of Cushing's syndrome. Atypical clinical presentations of hypercortisolism and some laboratory shortcomings that may confuse the diagnosis of Cushing's syndrome are also reported.

Entities:  

Mesh:

Year:  2001        PMID: 11253984     DOI: 10.1016/S0140-6736(00)04172-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  80 in total

1.  Tumor Lysis Syndrome in an Unusual Metastatic Pancreatic Neuroendocrine Tumor with Ectopic ACTH Secretion.

Authors:  Michael Shusterman; Noah A Bloomgarden; Susan T Sotardi; Aditi Shastri
Journal:  J Gastrointest Cancer       Date:  2016-12

Review 2.  Characterization of persistent and recurrent Cushing's disease.

Authors:  Nina K Sundaram; Alessia Carluccio; Eliza B Geer
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

3.  Results and long-term follow-up after unilateral adrenalectomy for ACTH-independent hypercortisolism in a series of fifty patients.

Authors:  M Iacobone; F Mantero; S M Basso; F Lumachi; G Favia
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

4.  Exacerbations of Graves' disease after unilateral adrenalectomy for Cushing's syndrome.

Authors:  E Arikan; S Guldiken; B Ugur Altun; M Kara; A Tugrul
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

Review 5.  The treatment of giant cell arteritis.

Authors:  J Alexander Fraser; Cornelia M Weyand; Nancy J Newman; Valérie Biousse
Journal:  Rev Neurol Dis       Date:  2008

6.  Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice.

Authors:  Wei Yao; Zhiqiang Cheng; Cheryl Busse; Aaron Pham; Mary C Nakamura; Nancy E Lane
Journal:  Arthritis Rheum       Date:  2008-06

7.  Selective inferior petrosal sinus sampling without venous outflow diversion in the detection of a pituitary adenoma in Cushing's syndrome.

Authors:  Lukas Andereggen; Gerhard Schroth; Jan Gralla; Rolf Seiler; Luigi Mariani; Jürgen Beck; Hans-Rudolf Widmer; Robert H Andres; Emanuel Christ; Christoph Ozdoba
Journal:  Neuroradiology       Date:  2011-08-02       Impact factor: 2.804

8.  GH secretion reserve in subclinical hypercortisolism.

Authors:  Serena Palmieri; Valentina Morelli; Antonio Stefano Salcuni; Cristina Eller-Vainicher; Elisa Cairoli; Volha V Zhukouskaya; Paolo Beck-Peccoz; Alfredo Scillitani; Iacopo Chiodini
Journal:  Pituitary       Date:  2014-10       Impact factor: 4.107

9.  Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing's disease.

Authors:  R van der Pas; C de Bruin; A M Pereira; J A Romijn; R T Netea-Maier; A R Hermus; P M Zelissen; F H de Jong; A J van der Lely; W W de Herder; S M Webb; S W J Lamberts; L J Hofland; R A Feelders
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

10.  Testosterone and bioavailable testosterone help to distinguish between mild Cushing's syndrome and polycystic ovarian syndrome.

Authors:  M E Pall; M C Lao; S S Patel; M L Lee; D E Ghods; D W Chandler; T C Friedman
Journal:  Horm Metab Res       Date:  2008-09-25       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.